Large scale healthcare services M&A has been mostly on hold in Europe for almost three years now. Despite all the economic and geopolitical uncertainty the world is currently facing, 2025 will probably see more activity.
The Dutch Health Minister, Fleur Agema, has once again rejected calls to ban private equity investments in the healthcare sector, facing down a parliamentary majority supporting such a move. In a letter to the Netherlands’ House of Representatives, Agema outlined four key reasons for her decision, prioritising the sector’s need for investment over legislator’s concerns […]
Circle Health, a healthcare provider operating Britain’s largest network of independent hospitals, has launched a business alternative for its subscription-based health insurance product “specifically aimed at keeping UK workers healthy”.
AXA Global Healthcare, offering global health insurance to expats, businesses, students and more, has announced the launch of Global Health Adapt, a new product designed to meet the needs of small and medium-sized enterprises (SMEs) with a globally based workforce.
Affidea, the pan-European provider of community based clinics, advanced diagnostics, and specialist services, has announced the acquisition of Sermesa polyclinics, a well-established healthcare provider in Valencia, Spain. The acquisition is intended to strengthen and expand Affidea’s outpatient and diagnostic services presence throughout Spain, as part of its wider strategy.
NorthEdge is a regionally focussed UK PE firm, headquartered in Manchester and with presence across the North and Midlands. It invests in lower mid-market companies across the healthcare, technology and business services sectors, and currently has £900m of assets under management.
In an interview with HBI, Phil Frame, Partner and Healthcare Investment Lead at NorthEdge, discussed some of the areas of healthcare innovation the firm is currently most excited about, and the abundant opportunity in the UK regions.
Europe’s occupational health market is seeing growing interest from investors as employers across the continent become increasingly amenable to taking a proactive approach to supporting their employees’ health. The sector is beginning to see significant M&A and PE acquisitions.
Lord Ara Darzi's eagerly anticipated independent review of the National Health Service (NHS) paints a stark picture of a health system in "critical condition" but with "vital signs" that remain strong.
At last year’s conference Hedley Goldberg, Managing Director at multinational investment bank Rothschild, predicted healthcare M&A activity would begin picking up again in Q4 2023 or Q1 2024. But we’re now halfway through 2024 and there are still very few deals above €500m taking place. Goldberg is confident, however, that we have now passed through the bottom of the cycle.
The morning of day three of HBI 2024 included sessions on the right model for AI, ophthalmology, diagnostic imaging, nuclear medicine and occupational health.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.